Skip to main content

megestrol

Generic: MEGESTROL ACETATE·Brand: MEGACE, MEGACE ES, MEGESTROL ACETATE

megestrol: 4 clinical trials tracked.

megestrol evidence translation

What we can confirm

4 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about megestrol, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence2 indications · 0 study sponsors

Related indications

CancerEndometrial Carcinoma

Study sponsors

No additional listed-company sponsor is linked.

Clinical Trial Registry Records (4)

Evaluating Promising Progestins in Endometrial Cancer Through a Rotating Umbrella Surgical Window Trial - The PRO-WINDOW TRIAL for Endometrial Cancer

NCT07436793Registry updated 2026-07-02·Phase 2
Recruiting

Primary endpoint: Tissue response to progestin therapy

InterventionalRandomizedopen140 targetStarted 2026-06Completion 2031-064 sites · United StatesNew Mexico Cancer Research Alliance

A Randomized Phase III Trial of Olanzapine Versus Megestrol Acetate for Cancer-Associated Anorexia

NCT04939090Registry updated 2026-07-30·Phase 3
Active, not recruiting

Primary endpoint: Change in appetite

InterventionalRandomizedopen227 enrolledStarted 2022-01Completion 2026-1250 sites · United StatesAlliance for Clinical Trials in Oncology

Open-Label Randomized Phase II Trial of Megestrol Acetate With or Without Pterostilbene in Patients With Endometrial Cancer Scheduled for Hysterectomy

NCT03671811Registry updated 2026-06-03·Phase 2
Active, not recruiting

Primary endpoint: Tumor Ki-67 Proliferation Index

InterventionalRandomizedopen44 targetStarted 2019-01Completion 2027-021 site · United StatesCity of Hope Medical Center

A Phase II Randomized Study to Assess the Benefit of a Metronomic Chemotherapy by Cyclophosphamide Versus Megestrol in Palliative Cancer

NCT00420563Registry updated 2026-09-17·Phase 2
Completed

Primary endpoint: Progression free survival rate at 2 months

InterventionalRandomizedopen88 enrolledStarted 2009-09Completion 2011-014 sites · FranceCentre Oscar Lambret